01 1Ajinomoto Co., Inc.
02 1Divi's Laboratories Limited
03 1Hetero Drugs Limited
04 1Maithri Drugs Private Limited
05 1Professional Compounding Centers of America dba PCCA
06 2Shandong Xinhua Pharmaceutical Company Limited
07 1Spectrum Laboratory Products, Inc.
08 2Teva Pharmaceutical Works Private Limited Company
09 1ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD.
01 3LEVODOPA
02 7Levodopa
03 1levodopa
01 3China
02 3India
03 2Israel
04 1Japan
05 1U.S.A
06 1United Kingdom
NDC Package Code : 17333-059
Start Marketing Date : 1982-04-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62331-013
Start Marketing Date : 2004-03-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65977-0126
Start Marketing Date : 1982-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51927-0049
Start Marketing Date : 2020-05-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 58624-0238
Start Marketing Date : 2000-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 58624-0234
Start Marketing Date : 2000-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49452-2680
Start Marketing Date : 1990-04-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51846-1053
Start Marketing Date : 2012-08-16
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51846-1052
Start Marketing Date : 2012-04-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 64220-199
Start Marketing Date : 2018-03-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Etilevodopa manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Etilevodopa, including repackagers and relabelers. The FDA regulates Etilevodopa manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Etilevodopa API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Etilevodopa manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Etilevodopa supplier is an individual or a company that provides Etilevodopa active pharmaceutical ingredient (API) or Etilevodopa finished formulations upon request. The Etilevodopa suppliers may include Etilevodopa API manufacturers, exporters, distributors and traders.
click here to find a list of Etilevodopa suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Etilevodopa as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Etilevodopa API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Etilevodopa as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Etilevodopa and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Etilevodopa NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Etilevodopa suppliers with NDC on PharmaCompass.
We have 9 companies offering Etilevodopa
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
